Quality Assessment of Hydroxychloroquine Tablet A Comparative Evaluation of Drug Produced by Different Pharmaceutical Companies in Bangladesh

Hydroxychloroquine is the most commonly prescribed antimalarial extensively used to treat rheumatoid arthritis. It is extensively utilized as a repurposing drug, as well, in many countries worldwide to treat COVID-19. The pharmaceutical sector of Bangladesh is much enriched, and different pharmaceut...

Full description

Bibliographic Details
Main Authors: Islam, Md. Raihanur, Hossain, Md. Sakhawat, Hossain, Md. Sanower, Islam, Mohammad Touhidul, Sultana, Sharifa, Nizhum, Nisarat, Ahamed, Kutub Uddin, Choo, Chee-Yan, Tan, Ching Siang, Goh, Khang Wen
Format: Article
Language:English
Published: HH Publisher 2023
Subjects:
Online Access:http://umpir.ump.edu.my/id/eprint/40749/
http://umpir.ump.edu.my/id/eprint/40749/1/Quality%20%20Assessment%20%20of%20%20Hydroxychloroquine%20%20Tablet%20%20A%20Comparative%20%20Evaluation%20%20of%20%20Drug%20%20Produced%20%20by%20%20Different%20Pharmaceutical%20Companies%20in%20Bangladesh.pdf
_version_ 1848826135025025024
author Islam, Md. Raihanur
Hossain, Md. Sakhawat
Hossain, Md. Sanower
Islam, Mohammad Touhidul
Sultana, Sharifa
Nizhum, Nisarat
Ahamed, Kutub Uddin
Choo, Chee-Yan
Tan, Ching Siang
Goh, Khang Wen
author_facet Islam, Md. Raihanur
Hossain, Md. Sakhawat
Hossain, Md. Sanower
Islam, Mohammad Touhidul
Sultana, Sharifa
Nizhum, Nisarat
Ahamed, Kutub Uddin
Choo, Chee-Yan
Tan, Ching Siang
Goh, Khang Wen
author_sort Islam, Md. Raihanur
building UMP Institutional Repository
collection Online Access
description Hydroxychloroquine is the most commonly prescribed antimalarial extensively used to treat rheumatoid arthritis. It is extensively utilized as a repurposing drug, as well, in many countries worldwide to treat COVID-19. The pharmaceutical sector of Bangladesh is much enriched, and different pharmaceutical companies in Bangladesh produce this drug. Since the drug quality might vary significantly among different brands, assuring the quality of medicine is absolutely necessary considering the health issues, particularly therapeutic efficacy and safety. Therefore, this study examined the quality of hydroxychloroquine produced by Bangladeshi pharmaceutical companies, concentrating on quality control parameters: the assay, dissolution, disintegration, hardness, friability, and weight fluctuation. All the brands of hydroxychloroquine tablets contained the stated amount of API between the range of 96.41±0.62 and 100.61±0.71 that met USP specification (100±5%). All brands met the pharmacopeial limit for the percentage of weight fluctuation, hardness test, friability, and disintegration time. Weight variation was between 0.31±0.01% and 0.46±0.02%, hardness was between 4.31 ± 0.88 and 7.36 ± 0.74 kgf, friability was less than 1%, and disintegration time was 5.42± 0.11 and 5.42± 0.11 min. In the dissolution test, all the samples attained more than 70% dissolution after 30 minutes. The mean percentage of hydroxychloroquine released in phosphate buffer was between 95.44±0.55 (Brand B) and 98.19±0.39 (Brand C) after 60 min. No significant difference was among the tested drugs from different companies, and all quality assessment parameters were within USP specifications. Therefore, hydroxychloroquine from the Bangladesh market is safe and effective.
first_indexed 2025-11-15T03:40:00Z
format Article
id ump-40749
institution Universiti Malaysia Pahang
institution_category Local University
language English
last_indexed 2025-11-15T03:40:00Z
publishDate 2023
publisher HH Publisher
recordtype eprints
repository_type Digital Repository
spelling ump-407492024-03-25T04:52:43Z http://umpir.ump.edu.my/id/eprint/40749/ Quality Assessment of Hydroxychloroquine Tablet A Comparative Evaluation of Drug Produced by Different Pharmaceutical Companies in Bangladesh Islam, Md. Raihanur Hossain, Md. Sakhawat Hossain, Md. Sanower Islam, Mohammad Touhidul Sultana, Sharifa Nizhum, Nisarat Ahamed, Kutub Uddin Choo, Chee-Yan Tan, Ching Siang Goh, Khang Wen Q Science (General) R Medicine (General) Hydroxychloroquine is the most commonly prescribed antimalarial extensively used to treat rheumatoid arthritis. It is extensively utilized as a repurposing drug, as well, in many countries worldwide to treat COVID-19. The pharmaceutical sector of Bangladesh is much enriched, and different pharmaceutical companies in Bangladesh produce this drug. Since the drug quality might vary significantly among different brands, assuring the quality of medicine is absolutely necessary considering the health issues, particularly therapeutic efficacy and safety. Therefore, this study examined the quality of hydroxychloroquine produced by Bangladeshi pharmaceutical companies, concentrating on quality control parameters: the assay, dissolution, disintegration, hardness, friability, and weight fluctuation. All the brands of hydroxychloroquine tablets contained the stated amount of API between the range of 96.41±0.62 and 100.61±0.71 that met USP specification (100±5%). All brands met the pharmacopeial limit for the percentage of weight fluctuation, hardness test, friability, and disintegration time. Weight variation was between 0.31±0.01% and 0.46±0.02%, hardness was between 4.31 ± 0.88 and 7.36 ± 0.74 kgf, friability was less than 1%, and disintegration time was 5.42± 0.11 and 5.42± 0.11 min. In the dissolution test, all the samples attained more than 70% dissolution after 30 minutes. The mean percentage of hydroxychloroquine released in phosphate buffer was between 95.44±0.55 (Brand B) and 98.19±0.39 (Brand C) after 60 min. No significant difference was among the tested drugs from different companies, and all quality assessment parameters were within USP specifications. Therefore, hydroxychloroquine from the Bangladesh market is safe and effective. HH Publisher 2023 Article PeerReviewed pdf en cc_by_nc_4 http://umpir.ump.edu.my/id/eprint/40749/1/Quality%20%20Assessment%20%20of%20%20Hydroxychloroquine%20%20Tablet%20%20A%20Comparative%20%20Evaluation%20%20of%20%20Drug%20%20Produced%20%20by%20%20Different%20Pharmaceutical%20Companies%20in%20Bangladesh.pdf Islam, Md. Raihanur and Hossain, Md. Sakhawat and Hossain, Md. Sanower and Islam, Mohammad Touhidul and Sultana, Sharifa and Nizhum, Nisarat and Ahamed, Kutub Uddin and Choo, Chee-Yan and Tan, Ching Siang and Goh, Khang Wen (2023) Quality Assessment of Hydroxychloroquine Tablet A Comparative Evaluation of Drug Produced by Different Pharmaceutical Companies in Bangladesh. Progress in Microbes and Molecular Biology, 6 (1). pp. 1-11. ISSN 2637-1049. (Published) https://doi.org/10.36877/pmmb.a0000336 10.36877/pmmb.a0000336
spellingShingle Q Science (General)
R Medicine (General)
Islam, Md. Raihanur
Hossain, Md. Sakhawat
Hossain, Md. Sanower
Islam, Mohammad Touhidul
Sultana, Sharifa
Nizhum, Nisarat
Ahamed, Kutub Uddin
Choo, Chee-Yan
Tan, Ching Siang
Goh, Khang Wen
Quality Assessment of Hydroxychloroquine Tablet A Comparative Evaluation of Drug Produced by Different Pharmaceutical Companies in Bangladesh
title Quality Assessment of Hydroxychloroquine Tablet A Comparative Evaluation of Drug Produced by Different Pharmaceutical Companies in Bangladesh
title_full Quality Assessment of Hydroxychloroquine Tablet A Comparative Evaluation of Drug Produced by Different Pharmaceutical Companies in Bangladesh
title_fullStr Quality Assessment of Hydroxychloroquine Tablet A Comparative Evaluation of Drug Produced by Different Pharmaceutical Companies in Bangladesh
title_full_unstemmed Quality Assessment of Hydroxychloroquine Tablet A Comparative Evaluation of Drug Produced by Different Pharmaceutical Companies in Bangladesh
title_short Quality Assessment of Hydroxychloroquine Tablet A Comparative Evaluation of Drug Produced by Different Pharmaceutical Companies in Bangladesh
title_sort quality assessment of hydroxychloroquine tablet a comparative evaluation of drug produced by different pharmaceutical companies in bangladesh
topic Q Science (General)
R Medicine (General)
url http://umpir.ump.edu.my/id/eprint/40749/
http://umpir.ump.edu.my/id/eprint/40749/
http://umpir.ump.edu.my/id/eprint/40749/
http://umpir.ump.edu.my/id/eprint/40749/1/Quality%20%20Assessment%20%20of%20%20Hydroxychloroquine%20%20Tablet%20%20A%20Comparative%20%20Evaluation%20%20of%20%20Drug%20%20Produced%20%20by%20%20Different%20Pharmaceutical%20Companies%20in%20Bangladesh.pdf